Powered by
FLINT—XlerateHealth, a national healthcare startup accelerator based in Louisville, Ky., announced the selection of six startup companies to its second annual cohort in Flint. The companies will participate in a …
EAST LANSING—The Michigan State University Foundation’s Conquer Accelerator announced the launch of its fifth season and summer 2020 cohort. The 10-week accelerator welcomes five selected teams to its East Lansing …
ANN ARBOR—The Michigan “angel investor” community released its 2019 annual research report, showing an increase in the number of angel investors and the amount they invested in Michigan startups last …
ANN ARBOR—The Michigan Growth Capital Symposium, the Midwest’s oldest and largest event for young companies seeking capital, will be held online Tuesday, May 5 as the Midwest Venture Showcase 2020. …
ANN ARBOR—After years of development, Nexletol, the new cholesterol-reducer from Ann Arbor’s Esperion Therapeutics Inc., is now on the market and available in pharmacies in the United States. Nexletol uses …
ANN ARBOR—Esperion Therapeutics Inc. (Nasdaq: ESPR) announced U.S. Food and Drug Administration approval of Nexlizet, a combination tablet of Esperion’s new non-statin cholesterol reducing drug bempedoic acid and an earlier …
LANSING—PlanetM, the mobility initiative of the Michigan Economic Development Corp., announced a fourth round of PlanetM Mobility Grants to four mobility and technology companies. PlanetM Mobility Grants are designed to …
ANN ARBOR—Millendo Therapeutics Inc. (Nasdaq: MLND), the developer of new endocrine drugs, announced the promotion of Thomas Hoover to the newly created position of chief commercial officer. Hoover joined Millendo …
SOUTHFIELD—Lear Corp. (NYSE: LEA), the automotive interiors technology developer, announced an undisclosed investment in Menlo Park, Calif.-based Autotech Ventures to support startups developing new mobility technologies. The investment is being …
ROYAL OAK—OncoCell MDx Inc., a startup incubated at Harvard University to develop sophisticated cancer diagnosis from a simple blood sample, announced that it has raised $22.2 million in a Preferred …